Within the Discussion Board area, write 250 words that respond to the following questions with your thoughts, ideas, and comments. This will be the foundation for future discussions by your classmates. You are required to use 1 scholarly resource in addition to your textbook. Be substantive and clear, and use examples to reinforce your ideas.
You are now the manager of your nursing department or clinical area. A new chief executive officer (CEO) has taken over the top leadership position and is requiring every nurse manager to develop at least one innovative strategy to promote quality patient care. Your CEO has requested you conduct an analysis of an innovation in health care. Address the following;
Choose 1 innovation from the following categories, and identify 1 particular area in your clinical setting in which this innovation is used:
Innovations in health care technology
Innovative products
Innovative designs
Innovative service delivery systems
Innovative operations
Discuss how this particular innovation is used in your clinical setting. PLEASE USE APA 7 WHEN WRITTING
Unit 2 Discussion Board: Innovations in Health Care Technology
Student’s Name
Institutional Affiliations
Unit 2 Discussion Board: Innovations in Health Care Technology
A number of healthcare innovation technologies are slowly transforming healthcare today. One of the technologies that are helping contemporary healthcare organizations to improve healthcare quality and patient outcomes is telehealth. Telehealth is a form of technology that entails the use of audio and videoconferencing on electronic devices such as smartphones and computers to connect providers with their patients remotely (Dekker et al., 2020). It offers a convenient and cost-effective way through which patients can access healthcare services without having to make physical office visits (Endsley, 2010). My clinical setting recently integrated telehealth technology into healthcare delivery during the wake of the coronavirus disease 2019 (COVID-19) pandemic to help prevent the spread of the disease by limiting the number of patient visits.
My clinical setting currently uses telehealth to increase healthcare access for patients with chronic conditions, particularly high blood pressure and type 2 diabetes. Hypertension and type 2 diabetes are diseases that require close patient monitoring for positive health outcomes to be realized (Gupta et al., 2021). The clinical setting is using telehealth to remotely monitor the progress of patients with these diseases. Using the technology, healthcare providers can design care plans for their patients and offer guidance on how to implement such plans. Additionally, patients use telehealth to express their concerns and seek clarifications regarding their treatment from their healthcare providers. Patients with chronic diseases such as hypertension and type 2 diabetes benefit a lot from integrated care that is offered by a team of healthcare providers. Telehealth technology allows the clinical setting to connect these patients with healthcare providers from different specialties (Dekker et al., 2020). In addition to protecting patients from contracting COVID-19, telehealth technology has helped to prevent patients from developing severe health complications, a factor that has helped to reduce the number of emergency room visits.
Dekker, P. K., Bhardwaj, P., Singh, T., Bekeny, J. C., Kim, K. G., Steinberg, J. S., Evans, K. K., Song, D. H., Attinger, C. E., & Fan, K. L. (2020). Telemedicine in the wake of the COVID-19 pandemic: Increasing access to surgical care. Plastic and Reconstructive Surgery. Global Open, 9(1), e3228. https://doi.org/10.1097/GOX.0000000000003228
Endsley, D. S. (2010). Innovation in action: A practical guide for healthcare teams. Wiley Global Research (STMS). https://coloradotech.vitalsource.com/books/9781119096290.
Gupta, A., Nayan, N., Nair, R., Kumar, K., Joshi, A., Sharma, S., Singh, J., & Kapoor, R. (2021). Diabetes mellitus and hypertension increase risk of death in novel corona virus patients irrespective of age: a prospective observational study of co-morbidities and COVID-19 from India. SN Comprehensive Clinical Medicine, 3(4), 937–944. https://doi.org/10.1007/s42399-021-00851-1